Literature DB >> 10878637

Transient sinus node dysfunction in acute myocardial infarction associated with the use of a coronary stent.

D Ahrensfield1, C W Balke, R M Benitez, R W Peters.   

Abstract

We describe a patient with acute inferior wall myocardial infarction who developed sinus node dysfunction following thrombosis of the sinus node artery during percutaneous transluminal coronary angioplasty and intracoronary stent implantation. Sinus node function normalized spontaneously over the next week, allowing beta blockers to be initiated. Our experience suggests that sinus node dysfunction in this setting may be transient and should be managed conservatively.

Entities:  

Mesh:

Year:  2000        PMID: 10878637     DOI: 10.1002/1522-726x(200007)50:3<349::aid-ccd18>3.0.co;2-#

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  Sinus arrest following stenting of the right coronary artery.

Authors:  Swee-Chong Seow; Wern-Miin Soo; Clara S Tolentino
Journal:  Heart Asia       Date:  2011-01-01

2.  Successful treatment of ischemic dysfunction of the sinus node with thrombolytic therapy: a case report.

Authors:  Jong-Seon Park; Dong-Gu Shin; Young-Jo Kim; Gu-Ru Hong; Hyung-Jun Kim; Bong-Sup Shim
Journal:  Korean J Intern Med       Date:  2006-12       Impact factor: 2.884

3.  Transient sinus arrest due to sinus node artery thrombus after revascularisation of the left circumflex artery.

Authors:  Muhammad Hamza Saad Shaukat; Alexey Tatusov; Anthony Nappi; Neil Yager
Journal:  BMJ Case Rep       Date:  2019-02-22

4.  Contemporary practice pattern of permanent pacing for conduction disorders in inferior ST-elevation myocardial infarction.

Authors:  Naoki Misumida; Gbolahan O Ogunbayo; John Catanzaro; Farshid Etaee; Sun Moon Kim; Ahmed Abdel-Latif; Khaled M Ziada; Claude S Elayi
Journal:  Clin Cardiol       Date:  2019-06-07       Impact factor: 2.882

5.  Sinus Node Dysfunction due to Occlusion of the Sinus Node Artery during Percutaneous Coronary Intervention.

Authors:  Ofir Koren; Dante Antonelli; Ranya Khamaise; Scott Ehrenberg; Ehud Rozner; Yoav Turgeman
Journal:  J Interv Cardiol       Date:  2021-03-30       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.